Allied Market Research
Loading...
0
New
New
2021
Endoscopic Retrograde Cholangiopancreatography Market

Endoscopic Retrograde Cholangiopancreatography Market by Product Type (Endoscopes, Endotherapy Devices, Imaging Systems, Energy Devices, And Others), Application (Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, And Pancreatic Duct Stenting), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, And Others): Global Opportunity Analysis and Industry Forecast, 2019-2027

A03846
Pages: 265
Apr 2021 | 3601 Views
   
Author(s) : Surabhi Pandey, Trupti Wadekar , Onkar Sumant
Tables: 122
Charts: 53
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Endoscopic Retrograde Cholangiopancreatography Market

Request Now !

The global endoscopic retrograde cholangiopancreatography market size was valued at $1,212.94 million in 2019, and is projected to reach $1,876.75 million by 2027, registering a CAGR of 5.6% from 2019 to 2027.

Endoscopy is a clinical process to observe body tissue or internal organs in detail or to conduct some minor surgery. Endoscopic retrograde cholangiopancreatography (ERCP) devices are medical equipment designed for pancreas to biliary system related disorders. These devices are gaining increased importance and adoption due to surge in prevalence of various bile ducts, and pancreatic and liver disorders such as Barrett's Disease., Biliary Disease, Colitis, Crohn's Disease, Gastroesophageal Reflux Disorder (GERD), liver Disease, Pancreatitis, Inflammatory Bowel Disease, Crohn’s Disease, Peptic Ulcer Disease. 

Endoscopic-Retrograde-Cholangiopancreatography-Market,-2019-2027

Get more information on this report : Request Sample Pages

The COVID-19 pandemic has had a major global impact on endoscopic services. Furthermore, the infection is transmitted through contact and droplets. Therefore, healthcare providers of endoscopy are facing tremendous risk during the pandemic as the spread is mainly through direct contact or aerosol droplets, and endoscopy procedures require a short physical distance between patients and personnel. A report from Hong Kong, based on experience with SARS, showed that the risk of infection is 5% for physicians, 4% for nurses, and 8% for healthcare assistants. It emphasized the importance of practicing strict isolation, infection control measures, and adherence to use of personal protective equipment (PPE). Hence, the endoscopic retrograde cholangiopancreatography market is negatively impacted by the COVID-19 pandemic.

The growth of the global endoscopic retrograde cholangiopancreatography (ERCP) market is majorly driven by rise in incidences of gastrointestinal and chronic biliary disorders such as Barrett's disease, biliary disease, colitis, Crohn's disease, gastroesophageal reflux disorder (GERD), liver Disease, pancreatitis, inflammatory bowel disease, and peptic ulcer disease. Further, rapid increasing frequencies of benign tumors of the liver and pancreas coupled with an increase in ageing population and surge in awareness related to devices used in ERCP for treatment of disorders. However, high costs associated with treatment from ERCP and side-effects of the procedure such as post-ERCP pancreatitis are expected to hamper the growth of the endoscopic retrograde cholangiopancreatography market. On the contrary, emerging countries possess high growth potential, owing to improvement of healthcare infrastructures in these countries. 

By product type, the endoscopic retrograde cholangiopancreatography (ERCP) market segmented into endoscopes, endotherapy devices, imaging systems, energy devices, and others. Further, endotherapy devices is divided into sphincterotome, lithotripter, stents, cannulas, forceps, snares, catheters, guiding wires, balloons, baskets, and others. By application, it is divided into biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. By end user, it is segregated into hospitals & clinics, ambulatory surgery centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America endoscopic retrograde cholangiopancreatography market accounted for the largest share in 2019 followed by Europe; however, the Asia-Pacific region is anticipated to grow with the highest CAGR during the forecast period. 

Product Type segment review

By product type, the endotherapy devices segment held the largest share in 2019 and is anticipated to maintain its dominance during the forecast period, owing to increase in demand for ERCP therapeutics procedures, and rise in prevalence of choledocholithiasis, gallbladder stones, pancreatitis, and other bile duct & pancreatic duct diseases. Further, by endotherapy devices, the stents and sphincterotome segments held the largest share in 2019 and is estimated to grow at a CAGR of 3.7% and 3.8% respectively during the forecast period.

Endoscopic Retrograde Cholangiopancreatography Market
By Product Type

Your browser does not support the canvas element.

Endotherapy Devices segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Application segment review

On the basis of application, the pancreatic sphincterotomy segment is expected to register highest CAGR during the forecast period, owing to increase in prevalence of population suffering from obstructing ductal calculi, ductal disruption & leak, sphincter stenosis, and dominant stricture of pancreas. Moreover, rise in demand for endoscopic technique which is used for various pancreas and pancreas-related diseases further fuels the growth of the endoscopic retrograde cholangiopancreatography market.

Endoscopic Retrograde Cholangiopancreatography Market
By Application

Your browser does not support the canvas element.

Surface Markers Separation Segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Region segment review

By region, North America accounted for the largest share in 2019, and is anticipated to maintain its dominance from 2019 to 2027, due to high expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR during the forecast period, as Governments of Asian countries are investing in the development of healthcare infrastructure.

Endoscopic Retrograde Cholangiopancreatography Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

Asia Pacific region would exhibit the highest CAGR of 7.0% during 2019-2027.

Get more information on this report : Request Sample Pages

Some of the key players operating in the global endoscopic retrograde cholangiopancreatography market include Olympus Corporation, Conmed Corporation, Hobbs Medical, Inc., TeleMed Systems, Inc., Boston Scientific Corporation, Cook Group Incorporation, Ambu, Inc., Becton, Dickinson and Company, Fujifilm Holding Corporation, and Medtronic Plc.

Key Benefits For Stakeholders

  • This report entails a detailed quantitative analysis along with the current global endoscopic retrograde cholangiopancreatography market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
  • The endoscopic retrograde cholangiopancreatography market forecast is studied from 2019 to 2027.
  • The endoscopic retrograde cholangiopancreatography market size and estimations are based on a comprehensive analysis of key developments in the endoscopic retrograde cholangiopancreatography industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the endoscopic retrograde cholangiopancreatography market.

Key Market Segments

By Product Type 

  • Endoscopes
  • Endotherapy Devices
    • Sphincterotome
    • Lithotripter
    • Stents
    • Cannulas
    • Forceps
    • Snares
    • Catheters
    • Guiding Wires
    • Balloons
    • Baskets
    • Others
  • Imaging Devices
  • Energy Devices
  • Others 

By Application 

  • Biliary Sphincterotomy
  • Biliary Dilatation
  • Biliary Stenting
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Dilatation
  • Pancreatic Duct Stenting

By End User

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

By Region 

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • South Africa
    • Saudi Arabia 
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description

1.1.1.Key benefits for stakeholders
1.1.2.Key market segments

1.2.Research methodology

1.2.1.Secondary research
1.2.2.Primary research
1.2.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Top player positioning, 2019
3.4.Porter’s five forces analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in incidences of gastrointestinal and chronic biliary disorders
3.5.1.2.Increase in frequencies of benign tumors of the liver and pancreas
3.5.1.3.Increase in ageing population

3.5.2.Restraints

3.5.2.1.High costs associated with treatment from ERCP devices
3.5.2.2.Side-effects of the procedure such as post-ERCP pancreatitis

3.5.3.Opportunity

3.5.3.1.Rise in awareness

3.6.Impact analysis of COVID-19 on market

CHAPTER 4:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Endoscopes

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Endotherapy Devices

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type

4.3.2.1.Sphincterotome

4.3.2.1.1.Market size and forecast

4.3.2.2.Lithotripter

4.3.2.2.1.Market size and forecast

4.3.2.3.Stents

4.3.2.3.1.Market size and forecast

4.3.2.4.Cannula

4.3.2.4.1.Market size and forecast

4.3.2.5.Forceps

4.3.2.5.1.Market size and forecast

4.3.2.6.Snare

4.3.2.6.1.Market size and forecast

4.3.2.7.Catheter

4.3.2.7.1.Market size and forecast

4.3.2.8.Guiding wires

4.3.2.8.1.Market size and forecast

4.3.2.9.Balloons

4.3.2.9.1.Market size and forecast

4.3.2.10.Basket

4.3.2.10.1.Market size and forecast

4.3.2.11.Others

4.3.2.11.1.Market size and forecast

4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country

4.4.Imaging Devices

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

4.5.Energy Devices

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

4.6.Others

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country

CHAPTER 5:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Biliary Sphincterotomy

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Biliary Dilatation

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Biliary Stenting

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Pancreatic Sphincterotomy

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

5.6.Pancreatic Duct Dilatation

5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country

5.7.Pancreatic Duct Stenting

5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country

CHAPTER 6:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals & Clinics

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Ambulatory surgery centers

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Others

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America endoscopy device market, by country

7.2.2.1.U.S. Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.2.2.U.S. Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.2.3.U.S. Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.2.2.4.Canada Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.2.5.Canada Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.2.6.Canada Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.2.2.7.Mexico Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.2.8.Mexico Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.2.9.Mexico Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.2.3.North America Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.4.North America Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.5.North America Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Endoscopic Retrograde Cholangiopancreatography Market, by country

7.3.2.1.Germany Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.2.Germany Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.3.Germany Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.4.France Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.5.France Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.6.France Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.7.UK Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.8.UK Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.9.UK Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.10.Italy Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.12.Italy Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.13.Italy Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.14.Spain Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.15.Spain Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.16.Spain Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.17.Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.18.Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.19.Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.3.3.Europe Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.4.Europe Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.5.Europe Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by country

7.4.2.1.Japan Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.2.Japan Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.3.Japan Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.4.China Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.5.China Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.6.China Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.7.Australia Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.8.Australia Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.9.Australia Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.10.India Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.11.India Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.12.India Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.13.South Korea Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.14.South Korea Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.15.South Korea Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.16.Rest of Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.17.Rest of Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.18.Rest of Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.4.3.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.4.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.5.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by country
7.5.2.1.Brazil Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.2.Brazil Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.3.Brazil Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.2.4.Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.5.Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.6.Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.2.7.South Africa Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.8.South Africa Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.9.South Africa Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.2.10.Rest of LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.11.Rest of LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.12.Rest of LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by end user

7.5.3.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.4.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.5.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by end user

CHAPTER 8:COMPANY PROFILES

8.1.AMBU INC.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.BECTON, DICKINSON AND COMPANY

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance

8.3.BOSTON SCIENTIFIC CORPORATION.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments

8.4.CONMED CORPORATION.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.COOK GROUP INCORPORATION

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio

8.6.HOBBS MEDICAL, INC.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio

8.7.FUJIFILM HOLDINGS CORPORATION.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.MEDTRONIC PLC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance

8.9.OLYMPUS CORPORATION

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.TELEMED SYSTEM, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio

LIST OF TABLES

TABLE 01.GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE 2019–2027 ($MILLION)
TABLE 02.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOSCOPES, BY REGION, 2019-2027 ($MILLION)
TABLE 03.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOTHERAPY DEVICES, BY TYPE, 2019-2027 ($MILLION)
TABLE 04.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOTHERAPY DEVICES, BY REGION, 2019-2027 ($MILLION)
TABLE 05.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR IMAGING DEVICES, BY REGION, 2019-2027 ($MILLION)
TABLE 06.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENERGY DEVICES, BY REGION, 2019-2027 ($MILLION)
TABLE 07.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
TABLE 08.GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY SPHINCTEROTOMY, BY REGION,  2019-2027 ($MILLION)
TABLE 10.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY DILATATION, BY REGION, 2019-2027 ($MILLION)
TABLE 11.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY STENTING BY REGION, 2019-2027 ($MILLION)
TABLE 12.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC SPHINCTEROTOMY BY REGION, 2019-2027 ($MILLION)
TABLE 13.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC DUCT DILATATION, BY REGION, 2019-2027 ($MILLION)
TABLE 14.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC DUCT STENTING, BY REGION, 2019-2027 ($MILLION)
TABLE 15.GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 16.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2027 ($MILLION)
TABLE 17.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 18.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 19.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 20.NORTH AMERICA ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 21.U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 22.U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 23.U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 24.CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 25.CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 26.CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 27.MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 28.MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 29.MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 30.NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 31.NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 32.NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 33.EUROPE ENDOSCOPY DEVICEMARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 34.GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 35.GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 36.GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 37.FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 38.FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 39.FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 40.UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 41.UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 42.UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 43.ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 44.ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 45.ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 46.SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 47.SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 48.SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 49.REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 50.REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 51.REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 52.EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 53.EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 54.EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 55.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 56.JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 57.JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 58.JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 59.CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 60.CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 61.CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 62.AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 63.AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 64.AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 65.INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 66.INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 67.INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 68.SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 69.SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 70.SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 74.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 75.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 76.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 77.LAMEA ENDOSCOPY DEVICEMARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 78.BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 79.BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 80.BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 81.SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 82.SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 83.SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 84.SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 85.SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 86.SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 87.REST OF LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 88.REST OF LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 89.REST OF LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 90.LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 91.LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 92.LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 93.AMBU: COMPANY SNAPSHOT
TABLE 94.AMBU: OPERATING SEGMENTS
TABLE 95.AMBU: PRODUCT PORTFOLIO
TABLE 96.BD: COMPANY SNAPSHOT
TABLE 97.BD: OPERATING SEGMENTS
TABLE 98.BD: PRODUCT PORTFOLIO
TABLE 99.BOSTON: COMPANY SNAPSHOT
TABLE 100.BOSTON: OPERATING SEGMENTS
TABLE 101.BOSTON: PRODUCT PORTFOLIO
TABLE 102.CONMED COMPANY SNAPSHOT
TABLE 103.CONMED: OPERATING SEGMENTS
TABLE 104.CONMED: PRODUCT PORTFOLIO
TABLE 105.COOK: COMPANY SNAPSHOT
TABLE 106.COOK: OPERATING SEGMENTS
TABLE 107.COOK: PRODUCT PORTFOLIO
TABLE 108.HOBBS MEDICAL: COMPANY SNAPSHOT
TABLE 109.HOBBS MEDICAL: OPERATING SEGMENTS
TABLE 110.HOBBS MEDICAL: PRODUCT PORTFOLIO
TABLE 111.FUJIFILM: COMPANY SNAPSHOT
TABLE 112.FUJIFILM: OPERATING SEGMENTS
TABLE 113.FUJIFILM: PRODUCT PORTFOLIO
TABLE 114.MEDTRONIC: COMPANY SNAPSHOT
TABLE 115.MEDTRONIC: OPERATING SEGMENTS
TABLE 116.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 117.OLYMPUS: COMPANY SNAPSHOT
TABLE 118.OLYMPUS: OPERATING SEGMENTS
TABLE 119.OLYMPUS: PRODUCT PORTFOLIO
TABLE 120.TELMED: COMPANY SNAPSHOT
TABLE 121.TELEMED: OPERATING SEGMENTS
TABLE 122.TELEMED: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS IN THE GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET
FIGURE 03.TOP PLAYER POSITIONING, 2019
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06.LOW THREAT OF NEW ENTRANTS
FIGURE 07.LOW THREAT OF SUBSTITUTION
FIGURE 08.HIGH COMPETITIVE RIVALRY
FIGURE 09.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOSCOPES BY COUNTRY, 2019–2027 (%)
FIGURE 10.ERCP MARKET FOR ENDOTHERAPY DEVICES BY SPHINCTEROTOME, 2019-2027
FIGURE 11.ERCP MARKET FOR ENDOTHERAPY DEVICES BY LITHOTRIPTER, 2019-2027
FIGURE 12.ERCP MARKET FOR ENDOTHERAPY DEVICES BY STENTS, 2019-2027
FIGURE 13.ERCP MARKET FOR ENDOTHERAPY DEVICES BY CANNULA, 2019-2027
FIGURE 14.ERCP MARKET FOR ENDOTHERAPY DEVICES BY FORCEPS, 2019-2027
FIGURE 15.ERCP MARKET FOR ENDOTHERAPY DEVICES BY SNARE, 2019-2027
FIGURE 16.ERCP MARKET FOR ENDOTHERAPY DEVICES BY CATHETER, 2019-2027
FIGURE 17.ERCP MARKET FOR ENDOTHERAPY DEVICES BY GUIDING WIRES, 2019-2027
FIGURE 18.ERCP MARKET FOR ENDOTHERAPY DEVICES BY BALLOON, 2019-2027
FIGURE 19.ERCP MARKET FOR ENDOTHERAPY DEVICES BY BASKET, 2019-2027
FIGURE 20.ERCP MARKET FOR ENDOTHERAPY DEVICES BY OTHERS, 2019-2027
FIGURE 21.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOTHERAPY DEVICES, BY COUNTRY, 2019–2027 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR IMAGING DEVICES, BY COUNTRY, 2019–2027 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENERGY DEVICES BY COUNTRY, 2019–2027 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR OTHERS BY COUNTRY, 2019–2027 (%)
FIGURE 25.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY SPHINCTEROTOMY, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY DILATATION, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 27.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY STENTING, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC SPHINCTEROTOMY, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 29.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC DUCT DILATATION, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC DUCT STENTING, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 31.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 33.COMPARATIVE ANALYSIS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 34.AMBU: NET SALES, 2018-2020 ($MILLION)
FIGURE 35.AMBU REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.AMBU: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.BD: NET SALES, 2018-2020 ($MILLION)
FIGURE 38.BD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.BD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 40.BOSTON: NET SALES, 2018-2020 ($MILLION)
FIGURE 41.BOSTON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42.BOSTON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43.CONMED: NET SALES, 2018-2020 ($MILLION)
FIGURE 44.CONMED: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 45.CONMED: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 46.FUJIFILM: NET SALES, 2018–2020 ($MILLION)
FIGURE 47.FUJIFILM: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 48.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 49.MEDTRONIC: REVENUE SHARE BY SEGMENTS, 2020 (%)
FIGURE 50.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 51.OLYMPUS: NET SALES, 2018–2020 ($MILLION)
FIGURE 52.OLYMPUS: REVENUE SHARE BY SEGMENTS, 2020(%)
FIGURE 53.OLYMPUS: REVENUE SHARE BY REGION, 2020 (%)

 
 

In accordance to several interviews conducted, the endoscopic retrograde cholangiopancreatography market is expected to witness a steady growth in the future. The market has drawn the interest of the healthcare industry, owing to increase in prevalence of choledocholithiasis, gallbladder stones, pancreatitis, and other bile duct & pancreatic duct diseases globally. The endoscopic retrograde cholangiopancreatography market is dominated by well-established players; hence, the market is anticipated to witness intense competition. The adoption of these devices has increased considerably, owing to adoption of technological advanced medical devices in the ERCP procedures, increase in gastrointestinal disorders, and rise in geriatric population, which propels the market growth. In addition, increase in product approval is expected to boost the market growth in the near future.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The major factor that fuels the growth of the Endoscopic Retrograde Cholangiopancreatography Market includes Increase in number of patients suffering from chronic disease and technological advancements in endosocpe and endotherpay devices primarily drive the growth of the Endoscopic Retrograde Cholangiopancreatography market. Similarly, surge in focus on personalized medicines for early detection of disease, selection of appropriate treatment, and determination of prognosis of the therapy are further expected to boost the market growth.

A. Yes, Endoscopic Retrograde Cholangiopancreatography companies are profiled in the report.

A. Olympus Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation, Cook Medical, and Conmed Corporation held a high market position in 2019.

A. Endotherapy Devices and endoscopes segment is the most influencing segment, owing to to increase in investments by the major players in the development of technologically advanced products as well as rising prevelance of diseases related to bile and pancreatic duct which fuels the growth of this segment.

A. The total market value of Endoscopic Retrograde Cholangiopancreatography Market is $1,213 million in 2019.

A. The forcast period for Endoscopic Retrograde Cholangiopancreatography Market is 2020 to 2027

A. The market value of Endoscopic Retrograde Cholangiopancreatography Market in 2020 is $1,139 million.

A. The base year is 2019 in Endoscopic Retrograde Cholangiopancreatography Market

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Endoscopic Retrograde Cholangiopancreatography Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers